|
|
 |
 |
|  |  |
 |  |  |  |  |
organism-gene
 |


|
 PR:Q9UPY6 |
   actin-binding protein WASF3 (human)
 |
   hWASF3
 |
  "An actin-binding protein WASF3 that is encoded in the genome of human." [PRO:DNx, UniProtKB:Q9UPY6]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:Q9UPY6-1 |
   actin-binding protein WASF3 isoform h1 (human)
 |
   hWASF3/iso:h1
 |
  "An actin-binding protein WASF3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UPY6-1." [PRO:DNx, UniProtKB:Q9UPY6]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:Q9UPY6-2 |
   actin-binding protein WASF3 isoform h2 (human)
 |
   hWASF3/iso:h2
 |
  "An actin-binding protein WASF3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UPY6-2." [PRO:DNx, UniProtKB:Q9UPY6]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000049673 |
   actin-binding protein WASF3 phosphorylated 1 (human)
 |
   hWASF3/Phos:1
 |
  "An actin-binding protein WASF3 (human) that has been phosphorylated on the residue at the position equivalent to Tyr-151 of the amino acid sequence represented by UniProtKB:Q9UPY6. UniProtKB:Q9UPY6, Tyr-151, MOD:00048." [PRO:DNx, Reactome:R-HSA-2029006]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000063654 |
   actin-binding protein WASF3 phosphorylated 2 (human)
 |
   hWASF3/Phos:2
 |
  "An actin-binding protein WASF3 (human) that has been phosphorylated on the residue at the position equivalent to Tyr-151 of the amino acid sequence represented by UniProtKB:Q9UPY6-1 and that includes at least one phosphorylated serine and at least one phosphorylated threonine. Example: UniProtKB:Q9UPY6-1, Tyr-151, MOD:00048|MOD:00046|MOD:00047." [PRO:DNx, Reactome:R-HSA-5672385]
 |

| 
|
|
|